The hepatitis C virus (HCV) is a significant public health problem of international importance. HCV is capable of establishing chronic infections resulting in progressive liver damage and other problems. Current drug therapies are ineffective, highlighting the need for better antiviral drugs. Recent research in HCV genetics and molecular biology have led to significant advances in our understanding of the life cycle of this important pathogen and may ultimately lead to better antiviral strategies. The editors of this book have recruited experts from around the world to produce a timely and well-compiled review of current HCV research, with an emphasis on antiviral drug development. The chapters provide in-depth reviews of the most critical areas of research. Topics include: the HCV life cycle * HCV assays * HCV resources * HCV databases * HCV infection systems * models of hepatitis C infections * overview of the drug pipeline * clinical trial design * clinical virology and drug development * NS3 protease inhibitors * NS3-NS4A complex inhibitors * NS3 helicase inhibitors * NS4B targets and inhibitors * NS5A inhibitors * nucleoside inhibitors * NS5B polymerase inhibitors * glycoprotein-dependent entry * host cell targets and inhibitors * innate immunity for HCV antiviral therapy.
"synopsis" may belong to another edition of this title.
In the vast field of the publications on hepatitis C, a book like this is sorely needed. The authors have succeeded in writing a meaningful, user-friendly guide to hepatitis C... The book covers may subjects, from basic virology, epidemiology, and diagnostic testing to treatment and dealing with side effects of the antiviral drugs. The information is condensed but well organized, so readers are not overwhelmed. (Cezarina Mindru for Doody's, July 2013)
Donald Jensen is the Director of the Center for Liver Disease, and is a Professor of Medicine at the University of Chicago Medical Center, Chicago, IL Nancy Reau is an Associate Professor of Medicine at the Center for Liver Disease, University of Chicago Medical Center, Chicago, IL
"About this title" may belong to another edition of this title.
Seller: -OnTimeBooks-, Phoenix, AZ, U.S.A.
Condition: good. A copy that has been read, remains in good condition. All pages are intact, and the cover is intact. The spine and cover show signs of wear. Pages can include notes and highlighting and show signs of wear, and the copy can include "From the library of" labels or previous owner inscriptions. 100% GUARANTEE! Shipped with delivery confirmation, if you're not satisfied with purchase please return item! Ships via media mail. Seller Inventory # OTV.1904455786.G
Seller: California Books, Miami, FL, U.S.A.
Condition: New. Seller Inventory # I-9781904455783
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New. Seller Inventory # 12682604-n
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition. Seller Inventory # 12682604
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition. Seller Inventory # 12682604
Quantity: Over 20 available
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New. Seller Inventory # 12682604-n
Quantity: Over 20 available
Seller: moluna, Greven, Germany
Gebunden. Condition: New. KlappentextrnrnThe hepatitis C virus (HCV) is a significant public health problem of international importance. HCV is capable of establishing chronic infections resulting in progressive liver damage and other problems. Current drug therapies are. Seller Inventory # 597150674
Quantity: Over 20 available
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
HRD. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L1-9781904455783
Quantity: Over 20 available
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
HRD. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L1-9781904455783
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Neuware - The hepatitis C virus (HCV) is a significant public health problem of international importance. HCV is capable of establishing chronic infections resulting in progressive liver damage and other problems. Current drug therapies are ineffective, highlighting the need for better antiviral drugs. Recent research in HCV genetics and molecular biology have led to significant advances in our understanding of the life cycle of this important pathogen and may ultimately lead to better antiviral strategies. The editors of this book have recruited experts from around the world to produce a timely and well-compiled review of current HCV research, with an emphasis on antiviral drug development. The chapters provide in-depth reviews of the most critical areas of research. Topics include: the HCV life cycle \* HCV assays \* HCV resources \* HCV databases \* HCV infection systems \* models of hepatitis C infections \* overview of the drug pipeline \* clinical trial design \* clinical virology and drug development \* NS3 protease inhibitors \* NS3-NS4A complex inhibitors \* NS3 helicase inhibitors \* NS4B targets and inhibitors \* NS5A inhibitors \* nucleoside inhibitors \* NS5B polymerase inhibitors \* glycoprotein-dependent entry \* host cell targets and inhibitors \* innate immunity for HCV antiviral therapy. Seller Inventory # 9781904455783